Accrued Expenses (Details) - Schedule of accrued expenses - USD ($) |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Schedule of accrued expenses [Abstract] | ||
Clinical research organization services and expenses | $ 1,826,479 | $ 470,991 |
Employee compensation | 520,795 | 322,437 |
Minimum license royalties | 40,000 | |
Manufacturing expenses | 17,060 | |
Legal and consulting services | 29,656 | 6,151 |
Total accrued expenses | $ 2,376,930 | $ 856,639 |
X | ||||||||||
- Definition Amount of clinical research organization services and expenses. No definition available.
|
X | ||||||||||
- Definition Amount of Legal and consulting services. No definition available.
|
X | ||||||||||
- Definition Amount of manufacturing expenses. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|